A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2δ GABAA receptors: The challenge in comparing apples with oranges.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmacological Research

• Publication date

  2016-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.phrs.2016.05.014PMID 27178730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High and low GABA sensitivity α4β2δ GABAA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometries.

  2016cited by this paper
• Oxytocin prevents ethanol actions at δ subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats

  2015cited by this paper
• GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.

  2015cited by this paper
• Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.

  2015cited by this paper
• γ-Aminobutyric Acid Type A α4, β2, and δ Subunits Assemble to Produce More Than One Functionally Distinct Receptor Type

  2014cited by this paper
• Etomidate produces similar allosteric modulation in α1β3δ and α1β3γ2L GABAA receptors

  2014cited by this paper
• Extrasynaptic GABAA Receptors Couple Presynaptic Activity to Postsynaptic Inhibition in the Somatosensory Thalamus

  2013cited by this paper
• Potency of GABA at human recombinant GABAA receptors expressed in Xenopus oocytes: a mini review

  2013cited by this paper
• A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABAA receptors

  2013cited by this paper
• Low nanomolar GABA effects at extrasynaptic α4β1/β3δ GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptors.

  2012cited by this paper
• Regulation of the surface expression of α4β2δ GABAA receptors by high efficacy states.

  2012cited by this paper
• GABA Potency at GABAA Receptors Found in Synaptic and Extrasynaptic Zones

  2012cited by this paper
• Characteristics of concatemeric GABAA receptors containing α4/δ subunits expressed in Xenopus oocytes

  2012cited by this paper
• Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.

  2012cited by this paper
• Unraveling the High- and Low-Sensitivity Agonist Responses of Nicotinic Acetylcholine Receptors

  2011cited by this paper
• Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA(A) receptors.

  2011cited by this paper
• Distinct activities of GABA agonists at synaptic‐ and extrasynaptic‐type GABAA receptors

  2010cited by this paper
• Protein Kinase C Phosphorylation Regulates Membrane Insertion of GABAA Receptor Subtypes That Mediate Tonic Inhibition*

  2010cited by this paper
• Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus.

  2009cited by this paper
• Etomidate, propofol and the neurosteroid THDOC increase the GABA efficacy of recombinant alpha4beta3delta and alpha4beta3 GABA A receptors expressed in HEK cells.

  2009cited by this paper
• NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy

  2008cited by this paper
• The expression of GABAAβ subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells

  2008cited by this paper
• Agonist-dependent Single Channel Current and Gating in α4β2δ and α1β2γ2S GABAA Receptors

  2008cited by this paper
• GABAA receptors in the thalamus: alpha4 subunit expression and alcohol sensitivity.

  2007cited by this paper
• GABAA receptors in the thalamus : α4 subunit expression and alcohol sensitivity

  2007cited by this paper
• Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.

  2006cited by this paper
• Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites

  2006cited by this paper
• Pharmacological Characterization of Agonists at δ-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of γ2

  2006cited by this paper
• Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4/6beta3delta GABAA receptors.

  2006cited by this paper
• Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to α4/6β3δ GABAA receptors

  2006cited by this paper
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors

  2005cited by this paper
• GABAA Receptor-Mediated Tonic Inhibition in Thalamic Neurons

  2005cited by this paper
• Extrasynaptic GABAA Receptors of Thalamocortical Neurons: A Molecular Target for Hypnotics

  2005cited by this paper
• Activation of GABA(A) receptors containing the alpha4 subunit by GABA and pentobarbital.

  2004cited by this paper
• Activation of GABAA receptors containing the α4 subunit by GABA and pentobarbital

  2004cited by this paper
• Slow Actions of Neuroactive Steroids at GABAA Receptors

  2004cited by this paper
• Perisynaptic Localization of δ Subunit-Containing GABAA Receptors and Their Activation by GABA Spillover in the Mouse Dentate Gyrus

  2003cited by this paper
• Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABAA receptors

  2003cited by this paper
• Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.

  2002cited by this paper
• Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors

  2002cited by this paper
• The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors.

  2002cited by this paper
• Segregation of Different GABAA Receptors to Synaptic and Extrasynaptic Membranes of Cerebellar Granule Cells

  1998cited by this paper

• Cerebellar tonic inhibition orchestrates the maturation of information processing and motor coordination

  2025cites this paper
• Loss-of-consciousness: sources of GABAergic input to the mesopontine tegmental anesthesia area

  2025cites this paper
• A subtype‐selective photoswitchable agonist for precise manipulation of GABAA receptors

  2025cites this paper
• Molecular and cellular targets of GABAergic anesthetics in the mesopontine tegmentum that enable pain-free surgery

  2024cites this paper
• Understanding paralogous epilepsy–associated GABAA receptor variants: Clinical implications, mechanisms, and potential pitfalls

  2024cites this paper
• Neurosteroids foster sedation by engaging tonic GABAA-Rs within the mesopontine tegmental anesthesia area (MPTA).

  2024cites this paper
• GABAA receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variants

  2023cites this paper
• Neurosteroids: mechanistic considerations and clinical prospects

  2023cites this paper
• The de novo GABRA4 p.Thr300Ile variant found in a patient with early‐onset intractable epilepsy and neurodevelopmental abnormalities displays gain‐of‐function traits

  2022cites this paper
• Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship

  2022cites this paper
• Pharmacological Evaluation of Drugs in Animal Models of Tinnitus.

  2021cites this paper
• A chronic low dosage of taurine induces muscle weakness in castrated-aged mice

  2021cites this paper
• The Influence of AA29504 on GABAA Receptor Ligand Binding Properties and Its Implications on Subtype Selectivity

  2021cites this paper
• Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy.

  2021cites this paper
• Structural Determinants for the Mode of Action of Imidazopyridine DS2 at δ-Containing γ-Aminobutyric Acid Type A Receptors.

  2021cites this paper
• Efficient expression of concatenated α1β2δ and α1β3δ GABAA receptors, their pharmacology and stoichiometry

  2021cites this paper
• A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro

  2020cites this paper
• Allosteric GABAA Receptor Modulators—A Review on the Most Recent Heterocyclic Chemotypes and Their Synthetic Accessibility

  2020cites this paper
• Ligand-gated ion channels in genetic disorders and the question of efficacy.

  2020cites this paper
• The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABAA Receptors Containing γ1, γ2, and γ3 Subunits

  2020cites this paper
• Structural Determinants for the Mode of Action of the Imidazopyridine DS2 at d-containing g-Aminobutyric Acid Type A (GABAA) Receptors

  2020cites this paper
• Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases.

  2019cites this paper
• Functional genomics of epilepsy-associated mutations in the GABAA receptor subunits reveal that one mutation impairs function and two are catastrophic

  2019cites this paper
• GABAA receptor desensitization shapes the kinetics and plasticity of inhibitory neurotransmission

  2019cites this paper
• The Delta-Subunit Selective GABAA Receptor Modulator, DS2, Improves Stroke Recovery via an Anti-inflammatory Mechanism

  2019cites this paper
• Taurine and GABA neurotransmitter receptors, a relationship with therapeutic potential?

  2019cites this paper
• Concatenated γ-aminobutyric acid type A receptors revisited: Finding order in chaos

  2019cites this paper
• Zebrafish behavioural profiling identifies GABA and serotonin receptor ligands related to sedation and paradoxical excitation

  2019cites this paper
• Functional properties and mechanism of action of PPTQ, an allosteric agonist and low nanomolar positive allosteric modulator at GABAA receptors

  2018cites this paper
• Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin‐induced Alzheimer's disease

  2018cites this paper
• Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors

  2018cites this paper
• Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABAA receptors

  2018cites this paper
• Concatenated nicotinic acetylcholine receptors: A gift or a curse?

  2018cites this paper
• Structure-Function Evaluation of Imidazopyridine Derivatives Selective for δ-Subunit-Containing γ-Aminobutyric Acid Type A (GABAA) Receptors.

  2018cites this paper
• The direct actions of cannabidiol and 2‐arachidonoyl glycerol at GABAA receptors

  2017cites this paper
• GABAA Receptors and the Diversity in their Structure and Pharmacology.

  2017cites this paper
• Comparison of &agr;&bgr;&dgr; and &agr;&bgr;&ggr; GABAA receptors: Allosteric modulation and identification of subunit arrangement by site‐selective general anesthetics

  2017cites this paper
• Taurine as an Essential Neuromodulator during Perinatal Cortical Development

  2017cites this paper
• Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models.

  2017cites this paper
• Contribution of Resting Conductance, GABAA-Receptor Mediated Miniature Synaptic Currents and Neurosteroid to Chloride Homeostasis in Central Neurons

  2017cites this paper
• Development of a Robust Mammalian Cell‐based Assay for Studying Recombinant α4β1/3δ GABAA Receptor Subtypes

  2017cites this paper
• Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings

  2017cites this paper
• Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.

  2016cites this paper